newsfilter
← Latest News
GlobeNewswire·

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology

MINNEAPOLIS, MN, US, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ:PETV, PETVW)) (the "Company" or "PetVivo") an emerging biomedical device company focused on the commercialization of innovative